BIO REFERENCE LABORATORIES INC
10-Q, EX-27, 2000-06-14
MEDICAL LABORATORIES
Previous: BIO REFERENCE LABORATORIES INC, 10-Q, 2000-06-14
Next: KENT ELECTRONICS CORP, 8-K, 2000-06-14



<TABLE> <S> <C>


<ARTICLE> 5
<LEGEND>
This Schedule  contains  summary  financial  information  extracted from (a) the
Balance Sheet and Statement of Operations  filed as part of the Quarterly Report
on Form 10-Q and is qualified in its entirety by reference to such (b) Report on
Form 10-Q.
</LEGEND>


<S>                                                            <C>
<PERIOD-TYPE>                                                  6-MOS
<FISCAL-YEAR-END>                                              OCT-31-2000
<PERIOD-END>                                                   APR-30-2000
<CASH>                                                           1,580,010
<SECURITIES>                                                             0
<RECEIVABLES>                                                   21,259,645
<ALLOWANCES>                                                    18,418,895
<INVENTORY>                                                        588,070
<CURRENT-ASSETS>                                                23,820,897
<PP&E>                                                           5,556,107
<DEPRECIATION>                                                   3,511,419
<TOTAL-ASSETS>                                                  35,208,383
<CURRENT-LIABILITIES>                                           20,190,522
<BONDS>                                                         14,851,282
                                                    0
                                                         60,408
<COMMON>                                                            81,405
<OTHER-SE>                                                      24,358,045
<TOTAL-LIABILITY-AND-EQUITY>                                    35,208,583
<SALES>                                                         31,315,702
<TOTAL-REVENUES>                                                31,315,702
<CGS>                                                           17,624,596
<TOTAL-COSTS>                                                   30,829,083
<OTHER-EXPENSES>                                                   701,467
<LOSS-PROVISION>                                                 4,046,399
<INTEREST-EXPENSE>                                                 743,580
<INCOME-PRETAX>                                                   (217,848)
<INCOME-TAX>                                                             0
<INCOME-CONTINUING>                                               (217,848)
<DISCONTINUED>                                                           0
<EXTRAORDINARY>                                                          0
<CHANGES>                                                                0
<NET-INCOME>                                                      (217,848)
<EPS-BASIC>                                                            .03
<EPS-DILUTED>                                                          .03



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission